The variability in ACE expression lets the ACE2 not linked to the virus free to convert angiotensin II into angiotensin 1-7, thus reducing the chance of pulmonary edema occurring during COVID-19 [59,60,61]. The gene discussed is ACE; the disease is COVID-19.